This video contains an introduction about the CellaVision DC-1, its main features and functionality, as well as a demonstration of the software with real cases.
This session will explore novel aspects of laboratory hematology that advance the diagnostic work-up of myeloid malignancies. A series of clinical case studies will be presented that highlight laboratory testing beyond the routine CBC. The examples and discussion will provide an overview of myeloid malignancy work-ups.
Multiparameter flow cytometry has become an integral tool in the work-up of abnormal WBC findings, allowing for rapid and accurate identification of abnormal cell populations, cell lineage assignment and assessment of clonality. This presentation will discuss a series of cases that demonstrate the utility of flow cytometry in the diagnostic workup of hematologic disorders presenting with abnormal WBC differential and incorporation of relevant criteria from the revised WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.
Advances in hematology testing offer parameters useful in assessing challenging conditions such as thrombocytopenia. This presentation provides an overview of immature platelet parameters (IPF% and IPF#) and discusses their clinical utility. Case studies will be presented to highlight the value of these parameters in assessing bone marrow activity and effective thrombopoiesis.
This presentation takes an in depth look at the function of lymphoid cells, describes their role in immunologic response, and outlines the impact to normal and abnormal processes. In addition, plasma cells and plasma cell myeloma will be reviewed using case studies to highlight ensuing patient conditions and associated findings.
This session will review the incidence, clinical significance, and diagnostic evaluation of anemia, iron deficiency and thrombocytopenia in neonates.
This presentation will explore how one institution was able to make effective use of the Advanced Hematology Parameters that include Immature Granulocytes (IG), Reticulocyte Hemoglobin (RET-He), and Immature Platelet Fraction (IPF).